An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer docume...
Saved in:
| Main Authors: | Mark Terence P. Mujer, Manoj P. Rai, Varunsiri Atti, Ian Limuel Dimaandal, Abigail S. Chan, Shiva Shrotriya, Krishna Gundabolu, Prajwal Dhakal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2020/7636104 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nephrotic Syndrome Thromboprophylaxis With Direct Oral Anticoagulants or Vitamin K Antagonists
by: Edouard Cubilier, et al.
Published: (2025-05-01) -
Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
by: Lama Alfehaid PharmD, MME, et al.
Published: (2025-08-01) -
Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists
by: Carlos Estevez-Fraga, et al.
Published: (2018-01-01) -
Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01) -
Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)